CALA vs. SCPS, STAB, ATHX, AMPE, APVO, IGNY, NVTA, PKBO, SMFL, and SIENQ
Should you be buying Calithera Biosciences stock or one of its competitors? The main competitors of Calithera Biosciences include Scopus BioPharma (SCPS), Statera Biopharma (STAB), Athersys (ATHX), Ampio Pharmaceuticals (AMPE), Aptevo Therapeutics (APVO), Ignyte Acquisition (IGNY), Invitae (NVTA), Peak Bio (PKBO), Smart for Life (SMFL), and Sientra (SIENQ). These companies are all part of the "medical" sector.
Scopus BioPharma (NASDAQ:SCPS) and Calithera Biosciences (NASDAQ:CALA) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their media sentiment, earnings, analyst recommendations, community ranking, dividends, risk, institutional ownership, profitability and valuation.
Calithera Biosciences received 339 more outperform votes than Scopus BioPharma when rated by MarketBeat users. However, 100.00% of users gave Scopus BioPharma an outperform vote while only 59.62% of users gave Calithera Biosciences an outperform vote.
Scopus BioPharma has higher earnings, but lower revenue than Calithera Biosciences.
In the previous week, Calithera Biosciences' average media sentiment score of 0.00 equaled Scopus BioPharma'saverage media sentiment score.
Summary
Scopus BioPharma and Calithera Biosciences tied by winning 2 of the 4 factors compared between the two stocks.
Get Calithera Biosciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for CALA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CALA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Calithera Biosciences Competitors List
Related Companies and Tools
